ALTEOGEN Inc
ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars. The company develops ALT-P1, a long-acting human growth hormone that is in the Phase IIa clinical trial; and ALT-Q2, a long-acting active form of coagulation factor VII for the treatment of hemophilia based on its NexP technology. It is also involved in the d… Read more
ALTEOGEN Inc (196170) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.013x
Based on the latest financial reports, ALTEOGEN Inc (196170) has a cash flow conversion efficiency ratio of -0.013x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-4.88 Billion) by net assets (₩377.92 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ALTEOGEN Inc - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how ALTEOGEN Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
ALTEOGEN Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ALTEOGEN Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
King Yuan Electronics Co Ltd
TW:2449
|
0.094x |
|
Huagong Tech Co Ltd
SHE:000988
|
0.040x |
|
OGE Energy Corporation
NYSE:OGE
|
0.077x |
|
Evolution AB (publ)
PINK:EVGGF
|
0.074x |
|
HF Sinclair Corp
NYSE:DINO
|
0.085x |
|
DAIMLER TRUCK SP.ADS/1/2
F:DTG1
|
N/A |
|
APA Corporation
NASDAQ:APA
|
0.213x |
|
Xero Limited
PINK:XROLF
|
0.132x |
Annual Cash Flow Conversion Efficiency for ALTEOGEN Inc (2014–2024)
The table below shows the annual cash flow conversion efficiency of ALTEOGEN Inc from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩274.09 Billion | ₩53.04 Billion | 0.194x | +468.44% |
| 2023-12-31 | ₩147.84 Billion | ₩-7.77 Billion | -0.053x | +56.29% |
| 2022-12-31 | ₩148.76 Billion | ₩-17.87 Billion | -0.120x | -73.66% |
| 2021-12-31 | ₩136.73 Billion | ₩-9.46 Billion | -0.069x | -700.12% |
| 2020-12-31 | ₩131.16 Billion | ₩1.51 Billion | 0.012x | -91.17% |
| 2019-12-31 | ₩69.98 Billion | ₩9.13 Billion | 0.131x | +195.42% |
| 2018-12-31 | ₩66.63 Billion | ₩-9.11 Billion | -0.137x | -25.37% |
| 2017-12-31 | ₩39.85 Billion | ₩-4.35 Billion | -0.109x | -56.21% |
| 2016-12-31 | ₩45.23 Billion | ₩-3.16 Billion | -0.070x | -218.91% |
| 2015-12-31 | ₩38.55 Billion | ₩2.26 Billion | 0.059x | +73.87% |
| 2014-12-31 | ₩35.82 Billion | ₩1.21 Billion | 0.034x | -- |